Thomassen, Emil Eirik Kvernberg http://orcid.org/0000-0003-2075-999X
Berg, Inger Jorid http://orcid.org/0000-0002-8605-5488
Kristianslund, Eirik Klami http://orcid.org/0000-0002-4963-3285
Tveter, Anne Therese http://orcid.org/0000-0003-1701-9835
Bakland, Gunnstein http://orcid.org/0000-0003-2613-5176
Gossec, Laure http://orcid.org/0000-0002-4528-310X
Hakim, Sarah http://orcid.org/0009-0006-3567-0313
Macfarlane, Gary John http://orcid.org/0000-0003-2322-3314
de Thurah, Annette http://orcid.org/0000-0003-0103-4328
Østerås, Nina http://orcid.org/0000-0001-8602-342X
Funding for this research was provided by:
Helse Sør-Øst RHF (2021062)
Norges Forskningsråd (328657)
University of Oslo
Article History
Received: 29 May 2024
Accepted: 27 July 2024
First Online: 21 August 2024
Declarations
:
: GB has received lecture honoraria from Janssen Pharmaceuticals. LG has received grants from AbbVie, Biogen, Lilly, Novartis, UCB. LG has received consulting fees from AbbVie, Amgen, BMS, Celltrion, Janssen, Novartis, Pfizer, UCB. LG has received lecture honoraria from AbbVie, Amgen, BMS, Celltrion, Janssen, Lilly, MSD, Novartis, Pfizer, Sandoz, UCB. LG has received support for meetings from MSD, Novartis, Pfizer. LG has participated in advisory boards at Janssen, Pfizer, UCB. LG received medical writing support from Abbvie, Amgen, Galapagos, Janssen, Pfizer, UCB.
: The study was conducted according to the Helsinki declaration and was approved by the Regional Committees for Medical and Health Research Ethics South East Norway (ref: 229187).